submental fat

Experts note the biggest impacts to derm in 2015We’re looking back on what made the biggest impacts on dermatology in 2015. This is what your peers had to say.
Avoiding Kybella complications
Avoiding Kybella complicationsDo you question Kybella’s safety? Medical experts offer insights and advice for how to avoid serious complications.
Submental fat? Making the right treatment choiceLiposuction, Kybella, CoolMini — How do you choose? CST Board Member Dr. Joe Niamtu advises.
Can Kybella be used to treat fat in areas other than the submental space?Dr. Jason Emer discusses the possibility of expanded treatment indications, compares Kybella with CoolMini and talks cost.
CoolMini to treat submental fatNew CoolMini applicator positions CoolSculpting as player in nonsurgical double chin treatment.
Nonsurgical double-chin treatment wins FDA approvalFDA’s approval of Kybella (deoxycholic acid), a less-invasive, non-surgical option for adults with moderate-to-severe fat below the chin, known as submental fat, or double chin, bodes well for the future of Kythera Biopharmaceuticals.
ATX-101 studies yield favorable findings for reducing submental fatTop-line results from North American phase 3 clinical trials show that a series of injections with ATX-101 is safe, well-tolerated, and results in clinically meaningful and statistically significant reductions in submental fat or “double chin.”
ATX-101 decreases submental fatSodium deoxycholate, an injectable therapy under study known as ATX-101 (Kythera) and not yet approved by the Food and Drug Administration, will present a noninvasive treatment option for patients who are concerned about the appearance of their submental fat or “double chin.”